Stockholm3 Detected More Significant Prostate Cancers Than PSA - Poll - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Stockholm3 Detected More Significant Prostate Cancers Than PSA

In a Swedish population-based screening cohort, the blood-based risk model had higher short-term sensitivity for clinically significant prostate cancer than prostate-specific antigen testing, with similar specificity.

  • By

  • Andrea Surnit

  • June 25, 2026

  • 5 min

Share

Original Source(s)

Stockholm3 Detected More Significant Prostate Cancers Than PSA

  • by Andrea Surnit

  • June 25, 2026

Related Content

Narrow DCIS Margins May Not Always Warrant Reexcision

An ancillary analysis found less than 2-percentage-point differences in 10-year recurrence across margin thresholds, with no statistically significant adjusted association.

Language Barriers Linked to Cancer Treatment Delays

Texas registry data point to neighborhood-level vulnerability as a possible target for improving timely colorectal cancer care.

Medical Oddities: When a Brush Beats a Scalpel

This research roundup has brain drama, bleeding control, skin science, and tiny brushes.